- Review
- Published:
Progress and prospects: Zinc-finger nucleases as gene therapy agents
Gene Therapyvolume 15, pages1463–1468 (2008)Cite this article
5818Accesses
177Citations
25Altmetric
Abstract
Zinc-finger nucleases (ZFNs) are powerful tools for experimental gene manipulation. A number of recent papers have shown how this technology can be applied effectively to models of human gene therapy. Significant target genes and useful methods of ZFN delivery have been reported. Important strides have been made in minimizing toxic side effects observed with some ZFNs, which bodes well for their ultimate safety. New tools are available for the design and testing of ZFNs for new target genes. Applications of ZFNs to stem cells have been described, and genuine gene therapy trials appear to be on the immediate horizon.
This is a preview of subscription content,access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
¥40,000 per year
only ¥6,667 per issue
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Cathomen T, Joung JK . Zinc-finger nucleases: the next generation emerges.Mol Therapy 2008;16: 1200–1207.
Porteus MH . Mammalian gene targeting with designed zinc finger nucleases.Mol Therapy 2006;13: 438–446.
Santiago Y, Chan E, Liu P-Q, Orlando S, Zhang L, Urnov FDet al. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases.Proc Natl Acad Sci USA 2008;105: 5809–5814.
Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee Y-L, Kim KAet al. Gene editiing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.Nat Biotechnol 2007;25: 1298–1306.
Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu Oet al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.Nat Biotechnol 2008;26: 808–816.
Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger Met al. Rapid ‘Open-Source’ engineering of customized zinc-finger nucleases for highly efficient gene modification.Mol Cell 2008;31: 294–301.
Meng X, Noyes MB, Zhu LJ, Lawson ND, Wolfe SA . Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases.Nat Biotechnol 2008;26: 695–701.
Doyon Y, MaCammon JM, Miller JC, Faraji F, Ngo C, Katibah GEet al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases.Nat Biotechnol 2008;26: 702–708.
Moehle EA, Rock JM, Lee Y-L, Jouvenot Y, DeKelver RC, Gregory PDet al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases.Proc Natl Acad Sci USA 2007;104: 3055–3060.
Beumer K, Bhattacharyya G, Bibikova M, Trautman JK, Carroll D . Efficient gene targeting inDrosophila with zinc finger nucleases.Genetics 2006;172: 2391–2403.
Morton J, Davis MW, Jorgensen EM, Carroll D . Induction and repair of zinc-finger nuclease-targeted double-strand breaks inCaenorhabditis elegans somatic cells.Proc Natl Acad Sci USA 2006;103: 16370–16375.
Minczuk M, Papworth MA, Miller JC, Murphy MP, Klug A . Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.Nucleic Acids Res 2008;36: 3926–3938.
Szczepek M, Brondani V, Buchel J, Serrano L, Segal DJ, Cathomen T . Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases.Nature Biotechnol 2007;25: 786–793.
Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JKet al. DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases.Mol Therapy 2008;16: 352–358.
Pruett-Miller SM, Connelly JP, Maeder ML, Joung JK, Porteus MH . Comparison of zinc-finger nucleases for use in gene targeting in mammalian cells.Mol Therapy 2008;16: 707–717.
Miller JC, Holmes MC, Wang J, Guschin DY, Lee Y-L, Rupniewski Iet al. An improved zinc-finger nuclease architecture for highly specific genome cleavage.Nature Biotechnology 2007;25: 778–785.
Carroll D, Morton JJ, Beumer KJ, Segal DJ . Design, construction andin vitro testing of zinc finger nucleases.Nature Protocols 2006;1: 1329–1341.
Mandell JG, Barbas III CF . Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases.Nucleic Acids Res 2006;34: W516–W523.
Wright DA, Thibodeau-Beganny S, Sander JD, Wiinfrey RJ, Hirsh AS, Eichtinger Met al. Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly.Nat Protoc 2006;1: 1637–1652.
Ramirez CL, Foley JE, Wright DA, Muller-Lerch F, Rahman SH, Cornu TIet al. Unexpected failure rates for modular assembly of engineered zinc fingers.Nat Methods 2008;5: 374–375.
Paques F, Duchateau P . Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy.Curr Gene Ther 2007;7: 49–66.
Calos MP . The phiC31 integrase system for gene therapy.Curr Gene Ther 2006;6: 633–645.
Author information
Authors and Affiliations
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA
D Carroll
- D Carroll
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toD Carroll.
Rights and permissions
About this article
Cite this article
Carroll, D. Progress and prospects: Zinc-finger nucleases as gene therapy agents.Gene Ther15, 1463–1468 (2008). https://doi.org/10.1038/gt.2008.145
Received:
Revised:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative